Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child

Journal of Infectious Diseases

Volumn 186, Issue 7, 2002, Pages 914-921

  Casper, Charlotte H E ^a,b   Clevestig, Peter ^a   Carlenor, Elisabeth ^a   Leitner, Thomas ^g   Anzén, Bo ^e   Lidman, Knut ^d   Belfrage, Erik ^c   Albert, Jan ^f   Bohlin, Ann Britt ^d   Navér, Lars ^a,d   Lindgren, Susanne ^d   Fenyö, Eva Maria ^a,h   Ehrnst, Anneka C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Neonatal Unit   (Sweden)

^c Childhood Cancer Research Unit   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f Division of Cardiovascular Epidemiology   (Sweden)

^g SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^h LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOTHER CHILD RELATION; PRIORITY JOURNAL; VIRUS TRANSMISSION; VIRUS TYPING; VIRUS VIRULENCE;

ADULT; CELL LINE; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECEPTORS, CCR5; RECEPTORS, CXCR4; TIME FACTORS;

EID: 0036786924     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/342948     Document Type: Article

References (55)

1. Berger EA, Doms RW, Fenyö EM, et al. A new classification for HIV-1 [letter]. Nature 1998;391:240.
2. Simmons G, Wilkinson D, Reeves JD, et al. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 1996;70:8355-60.
3. Björndal A, Deng H, Jansson M, et al. Co-receptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997;71:7478-87.
4. Zhang YJ, Dragic T, Cao Y, et al. Use of coreceptors other than CCR5 and CXCR4 by adult and pediatric isolates of HIV-1 is rare in vitro. J Virol 1998;72:9337-44.
5. Tscherning C, Alaeus A, Fredriksson R, et al. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998;241:181-8.
6. + cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-8.
7. Karlsson A, Parsmyr K, Sandström E, Fenyö EM, Albert J. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J Clin Microbiol 1994;32:364-70.
8. Connor RI, Sheridan KE, Ceradini S, Choe S, Landau NR. Change in co-receptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997;185:621-8.
9. Scarlatti G, Hodara V, Rossi P, et al. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. Virology 1993;197:624-9.
10. Kilks SC, Wara DW, Landers DV, Levy JA. Features of HIV-1 that could influence maternal-child transmission. JAMA 1994;272:467-74.
11. Carr JK, Foley BT, Leitner T, Korber B, McCutchan F. Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic. In: Korber B, Kiuken C, Foley B, et al., eds. Human retroviruses and AIDS, 1998. Los Alamos, New Mexico: Los Alamos National Laboratory, 1998:III.10-9.
12. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science 2000;288:55-6.
13. Hu DJ, Buvé A, Baggs J, van der Groen G, Dondero TJ. What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective. AIDS 1999;13:873-81.
14. Björndal A, Sönnerborg A, Tseherning C, Fenyö EM. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res Hum Retroviruses 1999;15:647-53.
15. Peeters M, Vincent R, Perret JL, et al. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:115-21.
16. Abebe A, Demissie D, Goudsmit J, et al. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients. AIDS 1999;13:1305-11.
17. Cecilia D, Kulkarni SS, Tripathy SP, Gangakhedkar RR, Paranjape RS, Gadkari DA. Absence of coreceptor switch with disease progression in HIV infections in India. Virology 2000;271:253-8.
18. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-80.
19. Lindgren S, Bohlin AB, Forsgren M, et al. Screening for HIV-1 antibodies in pregnancy: results from the Swedish national programme. BMJ 1993;307:1447-51.
20. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR-17):1-18.
21. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43(RR-12):1-10.
22. Lindgren S, Anzén B, Bohlin AB, Lidman K. HIV and child-bearing: clinical outcome and aspects of mother-to-infant transmission. AIDS 1991;5:1111-6.
23. Lindgren S, Martin C, Anzén B, Strand H, Bredberg-Råden U, Ehrnst A. Pattern of HIV viremia and CD4 levels in relation to pregnancy in HIV-1 infected women. Scand J Infect Dis 1996;28:425-33.
24. Contag CH, Ehrnst A, Duad J, et al. Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes. J Virol 1997;71:1292-300.
25. Navér L, Ehrnst A, Belfrage E, et al. Long-term pattern of HIV-1 RNA load in perinatally infected children. Scand J Infect Dis 1999;31:337-43.
26. Bailey A, Newell ML, Peckham C, et al., for the European Collaborative Study. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 1999;13:1377-85.
27. Navér L, Ehrnst A, Belfrage E, et al. Broad spectrum in time of detection, primary symptoms and disease progression in infants with HIV-1 infection. Eur J Clin Microbiol Infect Dis 2001;20:159-66.
28. Casper C, Navér L, Clevestig P, et al. Co-receptor change appears after the immune deficiency is established in children infected with different HIV-1 subtypes. AIDS Res Hum Retroviruses 2002;18:343-52.
29. Ehrnst A, Sönnerborg A, Bergdahl S, Strannegård Ö. Efficient isolation of HIV from plasma during different stages of HIV infection. J Med Virol 1988;26:23-32.
30. Ehrnst A, Lindgren S, Dictor M, et al. HIV in pregnant women and their offspring: evidence for late transmission. Lancet 1991;338:203-7.
31. Deng HK, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
32. Deng HK, Unutmaz D, KewalRamani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997;388:296-300.
33. Vödrös D, Tscherning-Casper C, Navea L, Schols D, De Clereq E, Fenyö EM. Quantitative evaluation of HIV-1 coreceptor use in the GHOST(3) cell assay. Virology 2001;291:1-11.
34. Tscherning-Casper C, Vödrös D, Menu E, et al. Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for In Utero Transmission of HIV-1. J Acquir Immune Defic Syndr 2000;24:1-9.
35. Leitner T, Korovina G, Marquina S, Smolskaya T, Albert J. Molecular epidemiology and MT-2 tropism of Russian HIV type 1 variants. AIDS Res Hum Retroviruses 1996;12:1595-603.
36. Felsenstein J. PHYLIP: phylogenetic inference package. Version 3.52c. Seattle: University of Washington, 1993.
37. Alaeus A, Lidman K, Sönnerborg A, Albert J. Subtype-specific problems with quantification of plasma HIV-1 RNA, AIDS 1997;11:859-65.
38. Dunn D, Brandt CD, Krivine A, et al. The sensitivity of HIV-1 PCR in the neonatal period and the relative contributions of intrauterine and intrapartum transmission. AIDS 1995;9:F7-11.
39. Ometto L, Zanchetta M, Mainardi M, et al. Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission. AIDS 2000;14:1721-9.
40. Husson RN, Lan Y, Kojima E, Venzon D, Mitsuya H, McIntosh K. Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype. J Pediatr 1995;126:865-71.
41. Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997;11:199-202.
42. Sönnerborg A, Durdevic S, Giesecke J, Sällberg M. Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993. AIDS Res Hum Retroviruses 1997;13:343-5.
43. Scarlatti G, Tresoldi E, Björndal A, et al. In vivo evolution of HIV-1 coreceptor usage and sensitivity to chemokine-mediated suppression. Nat Med 1997;3:1259-65.
44. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34.
45. Kollman TR, Pettoello-Mantovani M, Katopolis NF, et al. Inhibition of acute in vivo HIV infection by human IL-10 treatment of SCID mice implanted with human fetal thymus and liver. Proc Natl Acad Sci USA 1996;93:3126-31.
46. Patterson BK, Behbahani H, Kabat WJ, et al. Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest 2001;107:287-94.
47. Deschamps MM, Pape JW, Desvarieux M, et al. A prospective study of HIV-seropositive asymptomatic women of childbearing age in a developing country. J Acquir Immune Defic Syndr 1993;6:446-51.
48. Saada M, Le Chenadec J, Berrebi A, et al. Pregnancy and progression to AIDS: results of the French prospective cohorts. SEROGEST and SERECU study groups. AIDS 2000;14:2355-60.
49. Spencer LT, Ogino MT, Dankner WM, Spector SA. Clinical significance of HIV type 1 phenotypes in infected children. J Infect Dis 1994;169:491-5.
50. Reinhardt PP, Reinhardt B, Lathey J, Spector SA. Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic HIV-1 isolates. J Clin Microbiol 1995;33:292-7.
51. Ho WZ, Lioy J, Song L, Cutilli JR, Polin RA. Infection of cord blood-derived macrophages with HIV-1. J Virol 1992;66:573-9.
52. Dickover RE, Garratty EM, Plaeger S, Bryson YJ. Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J Virol 2001;75:2194-203.
53. - cells. Nature Med 2002;8:150-6.
54. Carreno MP, Chomont N, Kazatchkine MD, et al. Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells. J Virol 2002;76:32-40.
55. Pierson T, McArthur J, Siliciano RF, Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 2000l;18:665-708.